Matches in Nanopublications for { ?s ?p "[These results demonstrate the essential role of MADD in protecting cancer cells from TNFalpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP655646.RAcyucKi0yerO82-nWOw8Swaybv1FBjhjPH_H2IouKZP4130_assertion description "[These results demonstrate the essential role of MADD in protecting cancer cells from TNFalpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655646.RAcyucKi0yerO82-nWOw8Swaybv1FBjhjPH_H2IouKZP4130_provenance.
- NP614043.RACySu0RXHqt81caTkTdDgxzzeM8KpIAJsrD_vSSLMTWQ130_assertion description "[These results demonstrate the essential role of MADD in protecting cancer cells from TNFalpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614043.RACySu0RXHqt81caTkTdDgxzzeM8KpIAJsrD_vSSLMTWQ130_provenance.
- NP254125.RAvE1C6nmLj1afbyUPZa1q-R3wu08t8vmfToriz80bJnY130_assertion description "[These results demonstrate the essential role of MADD in protecting cancer cells from TNFalpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254125.RAvE1C6nmLj1afbyUPZa1q-R3wu08t8vmfToriz80bJnY130_provenance.
- NP790758.RAkl14RIJvkV2EdvvuLEnqHin9lLFZGFSosyH-GP1aoTI130_assertion description "[These results demonstrate the essential role of MADD in protecting cancer cells from TNFalpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790758.RAkl14RIJvkV2EdvvuLEnqHin9lLFZGFSosyH-GP1aoTI130_provenance.